Should the Health Community Promote Smokeless Tobacco (Snus) as a Harm Reduction Measure?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND TO THE DEBATE: The tobacco control community is divided on whether or not to inform the public that using oral, smokeless tobacco (Swedish snus) is less hazardous to health than smoking tobacco. Proponents of "harm reduction" point to the Swedish experience. Snus seems to be widely used as an alternative to cigarettes in Sweden, say these proponents, contributing to the low overall prevalence of smoking and smoking-related disease. Harm reduction proponents thus argue that the health community should actively inform inveterate cigarette smokers of the benefits of switching to snus. However, critics of harm reduction say that snus has its own risks, that no form of tobacco should ever be promoted, and that Sweden's experience is likely to be specific to that culture and not transferable to other settings. Critics also remain deeply suspicious that the tobacco industry will use snus marketing as a "gateway" to promote cigarettes. In the interests of promoting debate, the authors (who are collaborators on a research project on the future of tobacco control) have agreed to outline the strongest arguments for and against promoting Swedish snus as a form of harm reduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of smoke-free workplaces on smoking behaviour: systematic review
Fichtenberg, C. M., & Glantz, S. A. (2002) · BMJ · doi:10.1136/bmj.325.7357.188 · Cited by 1,072
Effect of smokeless tobacco (snus) on smoking and public health in Sweden
Foulds, J., Ramstrom, L., Burke, M., & Fagerström, K. (2003) · Tobacco Control · doi:10.1136/tc.12.4.349 · Cited by 471 · cited 3×
“Reviews of the Swedish experience have raised few doubts that its unprecedented decline in tobacco-caused mortality is associated with the rise of snus use at the expense of smoking [3,8].”
BackgroundLuo, J., Ye, W., Zendehdel, K., Adami, J., Adami, H.-O., Boffetta, P., & Nyrén, O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60678-3 · Cited by 242 · cited 1×
“Similar to other types of smokeless tobacco products, snus may increase the risk of some cancers [5,6,7], and there may be some risk of cardiovascular disease caused by nicotine.”
Background
Cited by
Berg, C. J., Stratton, E., Schauer, G. L., Lewis, M., Wang, Y., Windle, M., & Kegler, M. (2015) · Substance Use & Misuse · doi:10.3109/10826084.2014.958857 · Cited by 338
Ayers, J. W., Ribisl, K. M., & Brownstein, J. S. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.12.007 · Cited by 300
The Use and Perception of Electronic Cigarettes and Snus among the U.S. Population
Zhu, S.-H., Gamst, A., Lee, M., Cummins, S., Yin, L., & Zoref, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079332 · Cited by 271
Choi, K., Fabian, L., Mottey, N., Corbett, A., & Forster, J. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300525 · Cited by 216
Evaluation of In vitro Assays for Assessing the Toxicity of Cigarette Smoke and Smokeless Tobacco
Johnson, M. D., Schilz, J., Djordjevic, M. V., Rice, J. R., & Shields, P. G. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0965 · Cited by 162
“The Institute of Medicine, the World Health Organization Study Group on Tobacco Product Regulation and others have recognized that although there may be opportunities to reduce smoking-related harm, there are also risks to adopting harm reduction strategies (8-18).”
Background
Metadata
- Authors
- Gartner, C. E., Hall, W. D., Chapman, S., & Freeman, B.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-07-03
- Volume
- 4
- Issue
- 7
- Pages
- e185
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2116793552
- Cited by
- 104
- References
- 3
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.